SOLEUS CAPITAL MANAGEMENT, L.P. – CRISPR Therapeutics AG Transaction History
SOLEUS CAPITAL MANAGEMENT, L.P. portfolio value:
$1.43M
portfolio value
SOLEUS CAPITAL MANAGEMENT, L.P. quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 101K | $65.35 | 22K | |
| Q2 2022 | share | 0.00% | 0 shares | -44K | $60.77 | 22K | |
| Q1 2022 | share | 0.00% | 0 shares | -286K | $62.77 | 22K | |
| Q4 2021 | share | Decrease | -76.14% | -70.21K shares | -8.65M | $78.85 | 22K |
| Q3 2021 | share | Decrease | -10.57% | -10.9K shares | -6.37M | $111.93 | 92.21K |
| Q2 2021 | share | Increase | 0.00% | 103.11K shares | 16.69M | $161.89 | 103.11K |
| Q1 2021 | share | Decrease | -100.00% | -10.82K shares | -1.65M | $121.85 | 0 |
| Q4 2020 | share | Increase | +6.13% | 625 shares | 804K | $153.11 | 10.82K |
| Q3 2020 | share | Decrease | -40.70% | -7K shares | -411K | $83.64 | 10.2K |
| Q2 2020 | share | Increase | +4.88% | 800 shares | 568K | $73.49 | 17.2K |
| Q1 2020 | share | Decrease | -26.46% | -5.9K shares | -662K | $42.41 | 16.4K |
| Q4 2019 | share | Increase | 0.00% | 22.3K shares | 1.35M | $60.91 | 22.3K |